Clinical trial No longer in our active list Observational Ages 18 and up

Investigating the lung microbiome's impact on endobronchial valve treatment for emphysema

Official title: The Lung Microbiome in Patients With Emphysema and Chronic Obstructive Lung Disease Treated With Endobronchial Valves: Complications and Prognosis

Run by Aarhus University Hospital · NCT04932811 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to see how the bacteria in the lungs affect the success and complications of a treatment for emphysema in patients with COPD who are getting endobronchial valves.

More Chronic Obstructive Pulmonary Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus)
Trial IDNCT04932811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include COPD patients with emphysema who have been selected for EBV treatment by a multidisciplinary team.

Probably not a fit

Patients who have taken oral antibiotics within one month prior to the procedure may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how the lung microbiome affects outcomes and complications in patients with chronic obstructive pulmonary disease (COPD) and emphysema undergoing endobronchial valve (EBV) treatment. Patients will have bronchoalveolar lavage (BAL) performed before the insertion of EBVs, with the collected fluid analyzed for bacterial profiling. The study will track the incidence of infections and the need for valve removal or clean-up over a 24-month follow-up period, while also examining changes in the lung microbiome during these procedures.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of the lung microbiome's role in improving treatment outcomes for patients with emphysema undergoing EBV therapy.

How similar studies have gone: While the role of the lung microbiome in respiratory conditions is an emerging field, this specific approach to studying its impact on EBV treatment outcomes is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* COPD patients with emphysema selected for EBV treatment by multidiciplinary team, independent of this study.
* Written informed consent

Exclusion Criteria:

- Intake of oral antibiotics within 1 month before the procedure. Patients receiving preventive long-term treatment with antibiotics can be included.

Where it's running

  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Evaluating a new valve for lung volume reduction in COPD patients

    This study is testing a new valve to see if it can safely help people with COPD and emphysema breathe better and feel more active after a lung procedure.

    Recruiting China-Japan Friendship Hospital · Beijing, Beijing Municipality · NCT06349174

  • Registry for patients with emphysema and COPD

    This study is collecting information from people with emphysema and COPD to help researchers learn more about these lung diseases and improve future treatments.

    Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT00307281

  • Xenon MRI test for lung changes after Apreo BREATHE airway treatment in emphysema

    This study tests whether hyperpolarized Xenon MRI can show regional ventilation and gas-exchange changes after the Apreo BREATHE airway scaffolds in people with emphysema and air trapping.

    Recruiting Early Phase 1 Apreo Health, Inc. · Birmingham, Alabama and 1 other locations · NCT07896902

  • Flutter therapy added to chest physiotherapy after CABG in COPD patients

    This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.

    Recruiting Foundation University Islamabad · Rawalpindi · NCT07875049

  • TPB-based cadence exercise and breathing training for COPD patients

    A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.

    Recruiting Fu Jen Catholic University Hospital · New Taipei City, New Taipei City and 1 other locations · NCT07860008

  • See how dynamic chest X-rays relate to COPD patterns and progression risk

    This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.

    Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07762573

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.